
News from psychedelicalpha.com
Top psychedelicalpha.com News

Psychedelics · GermanyThe Marijuana Herald - Marijuana news and information In a historic move for psychedelic medicine, Germany has granted the first-ever compassionate use approval for psilocybin in the European Union. The authorization allows a patient with treatment-resistant depression to receive Filament Health’s botanical psilocybin drug candidate, PEX010, outside of a clinical trial setting.
The treatment will be administered by Dr. Gerhard Gründer at the Ce…See the Story
Filament Health Receives First-Ever Approval for Compassionate Use of Psilocybin in the EU

Kyrsten Sinema · United StatesAbbVie Eyes Billion-Dollar Gilgamesh Acquisition • What Is Kyrsten Sinema Selling? • Compass ‘Encouraged’ by Germany’s Psilocybin Compassionate Use Program • Psychedelics Industry’s Input on EMA’s Draft Depression Guideline • National Survey Reveals Psychedelics Use Again Rises in US • FDA Moves to Ban Kratom Compound 7-OH • Compass Talks Accelerated Approval on Q2’25 Earnings Call • atai All-In on Psychedelics Following RL-007 Flop • UK Governm…Read Article
Pα+ Psychedelic Bulletin #205: AbbVie Eyes Gilgamesh; Psychedelics Use Increases in U.S.; FDA Moves to Ban Kraton Compound 7-OH; What Is Sinema Selling? - Psychedelic Alpha

ConsciousnessIn her first Dispatch, Dr. Alaina Jaster covered the inaugural Neurobiology of Psychedelics Gordon Research Conference’s Keynote Sessio,n plus the first day of the gathering. Here, she covers the remainder: days 2, 3, and 4.Editor’s note: GRC has a strict publication policy; thus, the presenters referenced here provided consent for publication. Some of the speakers either did not consent or were… SourceRead Article